Skip to main content

Advertisement

Log in

Increased expression of l-amino acid transporters in balloon cells of tuberous sclerosis

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Objects

Tuberous sclerosis complex (TSC) is a dysgenetic syndrome involved in multiple organs, and the pathognomonic cortical tuber act as an epileptic substrate. The amino acid transport system L (LAT) is a major nutrient transport system, and LAT1 is highly expressed in malignant tumors to support tumor cell growth. To study the life-long epilepsy from the cortical tuber, the expression of LAT1 in balloon cells and dysplastic neurons of the cortical tuber is investigated.

Materials and methods

LAT1 expression was investigated by LAT1 mRNA using reverse transcription-polymerase chain reaction and immunohistochemical staining with anti-human LAT1 antibody in nine patients with TSC and three control brains.

Conclusion

LAT1 mRNA was detectable only in fresh-frozen tissues of TSC, and it was upregulated in the cortical tuber lesion. While the LAT1 immunopositivity of control brains was limited in the capillary endothelial cells in the gray matter, increased LAT1 immunopositivity was noted in balloon cells of the cortical tubers in addition to the capillary endothelial cells as shown in control brains. Linear and strong immunopositivity along the cell membrane and cytoplasm of the balloon cells, and weakly granular immunopositivity in their cytoplasm were noted. Increased expression of LAT1 in the balloon cells is important for the active transport of large neutral amino acids into the balloon cells, and that the biologic process may play an important role in the active protein synthesis with metabolic maintenance of balloon cells in cortical tubers of patients with TSC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Blondeau JP, Beslin A, Chantoux F, Francon J (1993) Triiodothyronine is a high-affinity inhibitor of amino acid transport system L1 in cultured astrocytes. J Neurochem 60:1407–1413

    Article  CAS  PubMed  Google Scholar 

  2. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (1999) Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 96:12079–12084

    Article  CAS  PubMed  Google Scholar 

  3. Campbell SL, Hablitz JJ (2008) Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia. Neurobiol Dis 32:254–261

    Article  CAS  PubMed  Google Scholar 

  4. Castagna M, Shayakul C, Trotti D, Sacchi VF, Harvey WR, Hediger MA (1997) Molecular characteristics of mammalian and insect amino acid transporters: implications for amino acid homeostasis. J Exp Biol 200:269–286

    CAS  PubMed  Google Scholar 

  5. Christensen HN (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70:43–77

    CAS  PubMed  Google Scholar 

  6. Crino PB, Henske EP (1999) New developments in the neurobiology of the tuberous sclerosis complex. Neurology 53:1384–1390

    CAS  PubMed  Google Scholar 

  7. del Amo EM, Urtti A, Yliperttula M (2008) Pharmacokinetic role of l-type amino acid transporters LAT1 and LAT2 european. J Pharm Sci 35:161–174

    Google Scholar 

  8. Gomes P, Soares-da-Silva P (1999) l-DOPA transport properties in an immortalized cell line of rat capillary cerebral endothelial cells, RBE 4. Brain Res 829:143–150

    Article  CAS  PubMed  Google Scholar 

  9. Hiroshi N, Naoki O, Nariyoshi S, Shinji F, Hidetoshi O, Katsuji S, Hirotaka M, Yoshikatsu K, Endou H (2006) l-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 119:484–492

    Article  Google Scholar 

  10. Hiroshi N, Naoki O, Nariyoshi S, Shinji F, Namiko N, Akiko Y, Katsuji S, Hirotaka M, Yoshikatsu K (2002) The role of CD98 in astrocytic neoplasms. Hum Cell 15:25–31

    Article  Google Scholar 

  11. Hiroshi N, Naoki O, Youichi U, Hidetoshi O, Terushige T, Takamoto S, Hiroshi K, Nobusuke T, Akira O, Katsuji S, Nariyoshi S, Hirotaka M, Yoshikatsu K (2005) High expression of l-type amino acid transporter 1 in infiltrating glioma cells. Brain Tumor Pathol 22:89–91

    Article  Google Scholar 

  12. Hirotaka M, Shingo T, Takahiro N, Arthit C, Kim DK, Cha SH, Jun I, Hiroshi Y, Jun F, Hitoshi E, Yoshikatsu K (2000) Expression of a system l neutral amino acid transporter at the blood-brain barrier. Neuropharm Neurotoxicol 169:3507–3511

    Google Scholar 

  13. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273:23629–23632

    Article  CAS  PubMed  Google Scholar 

  14. Kang NG, Chang HJ, Ok YC, Lee RS, Park SK, Lim JS, Cho KY, Kim HI, Kim JH, Oh HS, Lee MC (2007) Epileptogenic properties of balloon cells in cortical tubers of tuberous sclerosis: upregulation of drug resistance proteins. J Korean Neurosurg Soc 41:397–402

    CAS  Google Scholar 

  15. Kim DK, Kim IJ, Hwang S, Kook JH, Lee MC, Shin BA, Bae CS, Yoon JH, Ahn SG, Kim SA, Yoshikatsu K, Hitoshi E, Kim JK (2004) System l-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Neurosci Res 50:437–446

    Article  CAS  PubMed  Google Scholar 

  16. Kim SG, Kim HH, Kim HK, Kim CH, Chun HS, Kanai Y, Endou H, Kim DK (2006) Differential expression and functional characterization of system l amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells. Anticancer Res 26:1989–1996

    CAS  PubMed  Google Scholar 

  17. Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M (2008) Enhanced tumor growth elicited by l-type amino acid transporter 1 in human malignant glioma cells. Neurosurgery 62:493–504

    Article  PubMed  Google Scholar 

  18. Kuniaki N, Hirotaka M, Yoshikatsu K, Hitoshi E, Hi S, Susumu T, Makio M, Eiji I, Yuichi O, Shinsuke A, Toshiaki K (2006) LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Virchows Arch 448:142–150

    Article  Google Scholar 

  19. Kuzniecky RI, Barkovich AJ (1996) Pathogenesis and pathology of focal malformations of cortical development and epilepsy. J Clin Neurophysiol 13:468–480

    Article  CAS  PubMed  Google Scholar 

  20. Kyoichi K, Noboru O, Hisao I, Kimihiro S, Noriko Y, Noriaki S, Takeshi H, Osamu K, Hironobu I, Tamotsu I, Yoshikatsu K, Hitoshi E, Takashi N, Masatomo M (2008) Expression of l-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Pathol Res Pract 204:553–561

    Article  Google Scholar 

  21. Lee MC, Kim KM, Woo YJ, Kim MK, Kim JH, Nam SC, Suh JJ, Chung WK, Lee JS, Kim HI, Choi HY, Kim SU (2001) Pathogenic significance of neuronal migration disorders in temporal lobe epilepsy. Human Pathol 32:643–648

    Article  CAS  Google Scholar 

  22. Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB, Verrey F (1998) Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395:288–291

    Article  CAS  PubMed  Google Scholar 

  23. Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K, Matsuoka S, Noma A, Iwai K, Minato N (1999) 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 274:3009–3016

    Article  CAS  PubMed  Google Scholar 

  24. Oh HS, Lee MC, Kim HS, Lee JS, Lee JH, Kim MK, Woo YJ, Kim JH, Kim HI, Kim SU (2008) Pathophysiologic characteristics of balloon cells in cortical dysplasia. Childs Nerv Syst 24:175–183

    Article  PubMed  Google Scholar 

  25. Park NS, Kim SG, Kim HK, Moon SY, Kim CS, Cho SH, Kanai Y, Endou H, Kim DK (2008) Characterization of amino acid transport system L in HTB-41 human salivary gland epidermoid carcinoma cells. Anticancer Res 28:2649–2655

    CAS  PubMed  Google Scholar 

  26. Pfeiffer R, Spindler B, Loffing J, Skelly PJ, Shoemaker CB, Verrey F (1998) Functional heterodimeric amino acid transporters lacking cysteine residues involved in disulfide bond. FEBS Lett 439:157–162

    Article  CAS  PubMed  Google Scholar 

  27. Piedimonte LR, Wailes IK, Weiner HL (2006) Tuberous sclerosis complex: molecular pathogenesis and animal models. Neurosurg Focus 20:E4

    Article  PubMed  Google Scholar 

  28. Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, Lloberas J, Zorzano A, Palacin M (1999) Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an l-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 274:19738–19744

    Article  CAS  PubMed  Google Scholar 

  29. Raymond AA, Fish DR, Sisodiya SM, Alsanjari N, Stevens JM, Shorvon SD (1995) Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy. Clinical, EEG, and neuroimaging features in 100 adult patients. Brain 118:629–660

    Article  PubMed  Google Scholar 

  30. Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, Kuhn LC (1999) LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem 274:34948–34954

    Article  CAS  PubMed  Google Scholar 

  31. Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, Maat-Kievit A, Zonnenberg B, Verhoef S, Halley D, van den Ouweland A (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68:64–80

    Article  Google Scholar 

  32. Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, Maat-Kievit A, Zonnenberg B, Verhoef S, Halley D, van den Ouweland A (2005) Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet 13:731–741

    Article  CAS  PubMed  Google Scholar 

  33. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y (1999) Identification and functional characterization of a Na + -independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 274:19745–19751

    Article  CAS  PubMed  Google Scholar 

  34. Su TZ, Lunney E, Campbell G, Oxender DL (1995) Transport of gabapentin, a gamma-amino acid drug, by system l alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes and CHO cells. J Neurochem 64:2125–2131

    Article  CAS  PubMed  Google Scholar 

  35. Thom M, Martinian L, Sisodiya SM, Cross JH, Williams G, Stoeber K, Harkness W, Harding BN (2005) Mcm2 labelling of balloon cells in focal cortical dysplasia. Neuropathol Appl Neurobiol 31:580–588

    Article  CAS  PubMed  Google Scholar 

  36. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, Cha SH, Matsuo H, Fukushima J, Fukasawa Y, Tani Y, Taketani Y, Uchino H, Kim JY, Inatomi J, Okayasu I, Miyamoto K, Takeda E, Goya T, Endou H (2001) Human l-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514:291–302

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partially funded by the Clinical Research Institute, Chonnam National University Hospital (CRI 08051-1).

Disclosure

The authors report no conflict of interest concerning the materials or methods and the results in this study. Author contributions to the study and manuscript preparation include the following. Conception and design: all authors. Acquisition of data: all authors. Analysis and interpretation of data: Lim BC, Kim DK, Lee MC. Drafting the article: Lim BC, Kim HS, Lee KH, Lee MC. Reviewed final version of the manuscript and approved it for submission: all authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Min-Cheol Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lim, BC., Cho, KY., Lim, JS. et al. Increased expression of l-amino acid transporters in balloon cells of tuberous sclerosis. Childs Nerv Syst 27, 63–70 (2011). https://doi.org/10.1007/s00381-010-1239-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-010-1239-2

Keywords

Navigation